7856

🇹🇼 Tayvan Borsası
1875.00
TWD
Analysis Scores
Lothien Robustness Score?
33/100
Weak
Neden bu skor?
Damodaran ?
45/100
Dalio Risk ?
99/100
Piotroski ?
N/A
Yetersiz çeyrek verisi: 2 mevcut, en az 5 gerekli
Graham ?
-
Yetersiz çeyrek verisi: 2 mevcut, en az 4 gerekli
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
69/100
Lothien Sağlamlık: Güçlü (69/100)
Genel tablo olumlu. Finansal yapı sağlam, bazı riskler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 8 | Negatif: 3 | Nötr: 1
Net Kâr Pozitif
Son çeyrekte NT$330M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+301.0 arttı (NT$82M → NT$330M). Kısa vadede olumlu momentum.
Hasılat Büyümesi Güçlü
Satış gelirleri çeyreklik %+108.3 arttı (NT$576M → NT$1.2B). Talep güçlü.
Brüt Marj Genişliyor
Brüt kâr marjı %46.6 → %54.5 (+8.0 puan). Fiyatlama gücü artıyor veya maliyetler düşüyor.
Yüksek Net Kâr Marjı
Net kâr marjı %27.5. Her 100NT$ satıştan 28NT$ kâr kalıyor.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından NT$915M fazla. Borç riski düşük.
Güçlü Likidite
Cari oran 2.16x — kısa vadeli borçları rahat karşılıyor.
FAVÖK Büyümesi
FAVÖK çeyreklik %+302.2 arttı (NT$103M → NT$413M). Operasyonel verimlilik artıyor.
Yüksek F/K Uyarısı
Trailing F/K: 46.8. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Yüksek PD/DD
PD/DD: 33.96. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Yüksek EV/EBITDA
EV/EBITDA: 59.1. Pahalı değerleme.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-25.0 düşebilir. Sonraki bilançoya dikkat.

Data date 2026-11-19 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-11-19
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
252 days
Annual Volatility ?
%88.3
VaR 95% ?
%8.61
daily max loss
VaR 99% ?
%12.40
daily max loss
CVaR 95% ?
%9.93
expected loss (tail)
Max Drawdown ?
%64.6
27.08.2026 → 19.11.2026
Skewness ?
0.92
Parametrik%8.61
Historik%8.95
Cornish-Fisher%6.78
Return Distribution
Valuation
Potential?
-55.4%
ROIC ?
87.2%
DCF Value ?
296.22
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Son 2 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-48.0 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 3607.27 TWD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %27.5
Net profit margin %27.5 — very strong. Compared to previous quarter +13.2 point increase.
EBITDA Margin %34.4
EBITDA margin %34.4 — operationally very efficient.
Gross Profit Margin %54.5
Gross profit per revenue %54.5. Strong pricing power.
Valuation
P/E Ratio 46.8x Sector: 20.8x
F/K 46.8x — sector median's (20.8x) %125 above. Expensive zone.
P/B Ratio 33.96x Sector: 2.92x
PD/DD 33.96x — sector median's %1063 above. Expensive book value.
EV/EBITDA 59.1x Sector: 11.3x
EV/EBITDA 59.1x — sector median's (11.3x) %422 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 2.16x
Current ratio 2.16x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 0.1x
Net Debt/EBITDA 0.1x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.08x
Low leverage — majority of assets financed by equity.
Interest Coverage 106.6x
Interest coverage 106.6x — very wide margin for paying interest expenses.
Growth
No balance sheet data
Score Explanations
Lothien Robustness
33/100
Weak robustness (33/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-55.4%
Minus %55.4 expected value (835.89) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 572.58 | P/B target: 468.75 | EV/EBITDA target: 468.75 | DCF target: 468.75
Damodaran Valuation
45/100
Low Damodaran score (45/100). DCF analysis does not support current price.
Moderate
Dalio Risk Analysis
99/100
Low debt risk (99/100). Interest coverage ratio 106.6x — strong. Debt/EBITDA 0.1x — in healthy range.
Leverage: 97/100 | Debt Service: 100/100 | Quality: 100/100
ROIC - Return on Capital
%87.2
ROIC (%87.2) cost of capital 74.0 bps above → company creates value.
WACC: %13.2
DCF Discounted Cash Flow
296.22
DCF (296.22) current price %84.2 below — cash flows do not support current price.
Current price: 1875.00
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
—
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/E Ratio
46.8x vs 20.8x
Sector median's %125 above — expensive
P/B Ratio
33.96x vs 2.92x
Compared to sector %1063 more expensive (by book value)
EV/EBITDA
59.1x vs 11.3x
Compared to sector %422 higher EV/EBITDA
ROIC vs WACC
%87.2 vs %13.2 WACC
ROIC 74.0 bps above cost of capital
TRAMA-99 Trend — Strong Downtrend
Price (1875.00), TRAMA-99 line's %48.0 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 1875.00
TRAMA: 3607.27
Difference: %-48.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
7856 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.